INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

80 hedge funds and large institutions have $214M invested in Inozyme Pharma in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 9 closing their positions.

Holders
80
Holders Change
+3
Holders Change %
+3.9%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
13
Increased
42
Reduced
15
Closed
9
Calls
$1.44M
Puts
$100K
Net Calls
+$1.34M
Net Calls Change
+$891K
Name Holding Trade Value Shares
Change
Shares
Change %
Legal & General Group
76
Legal & General Group
United Kingdom
$17.2K +$4.49K +1,053 +35%
TRCT
77
Tower Research Capital (TRC)
New York
$16.6K -$18.9K -4,440 -53%
AB
78
Amalgamated Bank
New York
$13K -$1.5K -340 -10%
MLICM
79
Metropolitan Life Insurance Company (MetLife)
New York
$12.2K +$4.29K +1,006 +54%
Osaic Holdings
80
Osaic Holdings
Arizona
$213
Point72 Asset Management
81
Point72 Asset Management
Connecticut
-$2.94M -700,000 Closed
Marshall Wace
82
Marshall Wace
United Kingdom
-$570K -135,783 Closed
Mirae Asset Global Investments
83
Mirae Asset Global Investments
South Korea
-$233K -55,403 Closed
Squarepoint
84
Squarepoint
New York
-$179K -42,607 Closed
Walleye Capital
85
Walleye Capital
New York
-$147K -35,058 Closed
SO
86
STRS Ohio
Ohio
-$41K -9,900 Closed
Group One Trading
87
Group One Trading
Illinois
-$4.24K -1,009 Closed
Simplex Trading
88
Simplex Trading
Illinois
-$4K -1,001 Closed
US Bancorp
89
US Bancorp
Minnesota
-$542 -129 Closed